These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35763567)

  • 21. The era of Cas12 and Cas13 CRISPR-based disease diagnosis.
    Singh M; Bindal G; Misra CS; Rath D
    Crit Rev Microbiol; 2022 Nov; 48(6):714-729. PubMed ID: 35164636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative performance of CRISPR-Cas12a assays for SARS-CoV-2 detection tested with RNA extracted from clinical specimens.
    Nimsamer P; Mayuramart O; Rattanaburi S; Chantaravisoot N; Saengchoowong S; Puenpa J; Poovorawan Y; Payungporn S
    J Virol Methods; 2021 Apr; 290():114092. PubMed ID: 33539846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitive and Easy-Read CRISPR Strip for COVID-19 Rapid Point-of-Care Testing.
    Li H; Dong X; Wang Y; Yang L; Cai K; Zhang X; Kou Z; He L; Sun S; Li T; Nie Y; Li X; Sun Y
    CRISPR J; 2021 Jun; 4(3):392-399. PubMed ID: 34152219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Massively multiplexed nucleic acid detection with Cas13.
    Ackerman CM; Myhrvold C; Thakku SG; Freije CA; Metsky HC; Yang DK; Ye SH; Boehm CK; Kosoko-Thoroddsen TF; Kehe J; Nguyen TG; Carter A; Kulesa A; Barnes JR; Dugan VG; Hung DT; Blainey PC; Sabeti PC
    Nature; 2020 Jun; 582(7811):277-282. PubMed ID: 32349121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CREST, a Cas13-Based, Rugged, Equitable, Scalable Testing (CREST) for SARS-CoV-2 Detection in Patient Samples.
    Aralis Z; Rauch JN; Audouard M; Valois E; Lach RS; Solley S; Baxter NJ; Kosik KS; Wilson MZ; Acosta-Alvear D; Arias C
    Curr Protoc; 2022 Feb; 2(2):e385. PubMed ID: 35195954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comprehensive analysis and resource to use CRISPR-Cas13 for broad-spectrum targeting of RNA viruses.
    Lin X; Liu Y; Chemparathy A; Pande T; La Russa M; Qi LS
    Cell Rep Med; 2021 Apr; 2(4):100245. PubMed ID: 33778788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hybrid CRISPR/Cas protein for one-pot detection of DNA and RNA.
    Guk K; Yi S; Kim H; Bae Y; Yong D; Kim S; Lee KS; Lim EK; Kang T; Jung J
    Biosens Bioelectron; 2023 Jan; 219():114819. PubMed ID: 36327561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simplified Cas13-based assays for the fast identification of SARS-CoV-2 and its variants.
    Arizti-Sanz J; Bradley A; Zhang YB; Boehm CK; Freije CA; Grunberg ME; Kosoko-Thoroddsen TF; Welch NL; Pillai PP; Mantena S; Kim G; Uwanibe JN; John OG; Eromon PE; Kocher G; Gross R; Lee JS; Hensley LE; MacInnis BL; Johnson J; Springer M; Happi CT; Sabeti PC; Myhrvold C
    Nat Biomed Eng; 2022 Aug; 6(8):932-943. PubMed ID: 35637389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Throughput CRISPR-Cas13 SARS-CoV-2 Test.
    Manning BJ; Khan WA; Peña JM; Fiore ES; Boisvert H; Tudino MC; Barney RE; Wilson MK; Singh S; Mowatt JA; Thompson HJ; Tsongalis GJ; Blake WJ
    Clin Chem; 2021 Dec; 68(1):172-180. PubMed ID: 34718481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Programmed DNA destruction by miniature CRISPR-Cas14 enzymes.
    Harrington LB; Burstein D; Chen JS; Paez-Espino D; Ma E; Witte IP; Cofsky JC; Kyrpides NC; Banfield JF; Doudna JA
    Science; 2018 Nov; 362(6416):839-842. PubMed ID: 30337455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted Delivery of CRISPR/Cas13 as a Promising Therapeutic Approach to Treat SARS-CoV-2.
    Abbaszadeh-Goudarzi K; Nematollahi MH; Khanbabaei H; Nave HH; Mirzaei HR; Pourghadamyari H; Sahebkar A
    Curr Pharm Biotechnol; 2021; 22(9):1149-1155. PubMed ID: 33038909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of SARS-CoV-2 by CRISPR/Cas12a-Enhanced Colorimetry.
    Jiang Y; Hu M; Liu AA; Lin Y; Liu L; Yu B; Zhou X; Pang DW
    ACS Sens; 2021 Mar; 6(3):1086-1093. PubMed ID: 33683104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells.
    Lin P; Qin S; Pu Q; Wang Z; Wu Q; Gao P; Schettler J; Guo K; Li R; Li G; Huang C; Wei Y; Gao GF; Jiang J; Wu M
    Mol Cell; 2020 Jun; 78(5):850-861.e5. PubMed ID: 32348779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of severe acute respiratory syndrome coronavirus 2 and influenza viruses based on CRISPR-Cas12a.
    Mayuramart O; Nimsamer P; Rattanaburi S; Chantaravisoot N; Khongnomnan K; Chansaenroj J; Puenpa J; Suntronwong N; Vichaiwattana P; Poovorawan Y; Payungporn S
    Exp Biol Med (Maywood); 2021 Feb; 246(4):400-405. PubMed ID: 33153299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detect and destroy: CRISPR-based technologies for the response against viruses.
    Freije CA; Sabeti PC
    Cell Host Microbe; 2021 May; 29(5):689-703. PubMed ID: 33915112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay.
    Ding X; Yin K; Li Z; Lalla RV; Ballesteros E; Sfeir MM; Liu C
    Nat Commun; 2020 Sep; 11(1):4711. PubMed ID: 32948757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid, Sensitive, and Specific Severe Acute Respiratory Syndrome Coronavirus 2 Detection: A Multicenter Comparison Between Standard Quantitative Reverse-Transcriptase Polymerase Chain Reaction and CRISPR-Based DETECTR.
    Brandsma E; Verhagen HJMP; van de Laar TJW; Claas ECJ; Cornelissen M; van den Akker E
    J Infect Dis; 2021 Feb; 223(2):206-213. PubMed ID: 33535237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of mobile real-time polymerase chain reaction tests for the detection of severe acute respiratory syndrome coronavirus 2.
    Onyilagha C; Mistry H; Marszal P; Pinette M; Kobasa D; Tailor N; Berhane Y; Nfon C; Pickering B; Mubareka S; Bulir D; Chong S; Kozak R; Ambagala A
    Sci Rep; 2021 Apr; 11(1):9387. PubMed ID: 33931684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
    Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
    Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amplification-free RNA detection with CRISPR-Cas13.
    Shinoda H; Taguchi Y; Nakagawa R; Makino A; Okazaki S; Nakano M; Muramoto Y; Takahashi C; Takahashi I; Ando J; Noda T; Nureki O; Nishimasu H; Watanabe R
    Commun Biol; 2021 Apr; 4(1):476. PubMed ID: 33875803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.